Am J Cardiol
- BELLICINI DMG
Hypertensive Heart Disease: Risk Marker or Causal Substrate of Heart Failure?
Am J Cardiol. 2026 Jun 22:S0002-9149(26)00430.
Am J Hypertens
- KOUNTOURAS J, Polyzos SA, Vardaka E, Zavos C, et al
Chronic infection and metabolic stress: a converging axis driving hypertension
and MASLD outcomes.
Am J Hypertens. 2026 Jun 22:hpag064. doi: 10.1093.
- DONG G, Xie D
Methodological considerations for refining the prognostic utility of the HALP
score in populations with hypertension.
Am J Hypertens. 2026 Jun 19:hpag062. doi: 10.1093.
- JIANG J
Competing Risk of Death and the Hypertension-Atrial Fibrillation Association in
Diabetes.
Am J Hypertens. 2026 Jun 19:hpag063. doi: 10.1093.
Am J Med
- SALABEI JK
Why Is Hypertension Reaching the Cardiologist? Observations From a Community
Practice.
Am J Med. 2026 Jun 20:S0002-9343(26)00498-5. doi: 10.1016/j.amjmed.2026.
Am J Med Sci
- RAM CVS
Chlorthalidone vs. hydrochlorothiazide in hypertension management: Lessons for
guiding clinical practice.
Am J Med Sci. 2026 Jun 20:S0002-9629(26)00240.
Circulation
- NGUYEN M, AlEssa HB, Glenn AJ, Tobias DK, et al
Consumption of Fructose-Containing Food and Beverage Sources in Childhood Through
to Adulthood and Risk of Hypertension: A Prospective Cohort Study.
Circulation. 2026 Jun 22:10.1161/CIRCULATIONAHA.125.077666.
- ALKHODARI M, Lapidaire W, Kart T, Xiong Z, et al
Contrastive Machine Learning to Quantify Hypertensive Multiorgan Damage and
Identify New Disease Phenotypes: A Multinational Multimodal Study.
Circulation. 2026 Jun 21. doi: 10.1161/CIRCULATIONAHA.125.077394.
Clin Cardiol
- SHAHAB L, Khan SH, Zain JK
Methodological Issues Related to the Reported Association of A Body Shape Index
With Abdominal Aortic Calcification in Patients With Hypertension.
Clin Cardiol. 2026;49:e70390.
- FALODIA R, Alokozay E, Idrees M, Paghdar D, et al
Efficacy and Safety of Baxdrostat for Hypertension: A Systematic Review and
Meta-Analysis of Three Phase 2/3 Randomized Controlled Trials.
Clin Cardiol. 2026;49:e70391.
Eur Heart J
- NOLDE JM, Kiuchi MG, Webster M, Wilkins G, et al
Combined hepatorenal denervation for hypertension and cardiometabolic disease: a
first-in-human study.
Eur Heart J. 2026 Jun 19:ehag460. doi: 10.1093.
Hypertension
- QIAO Y, Sun Z, Harshfield EL, Ji X, et al
Blood Pressure Variability and Outcomes Across Antihypertensive Regimens.
Hypertension. 2026 Jun 25. doi: 10.1161/HYPERTENSIONAHA.126.27140.
- FORD CD, Cameron NA, Clark D 3rd, Derington CG, et al
Rural Health and Health Disparities in Hypertension Management: A Scientific
Statement From the American Heart Association.
Hypertension. 2026 Jun 25. doi: 10.1161/HYP.0000000000000263.
J Hypertens
- SIMEUNOVIC A, Brunborg C, Heier M, Berg TJ, et al
Increased 24-h blood pressure and arterial stiffness in young adults with
childhood-onset type 1 diabetes: the Norwegian Atherosclerosis and Childhood
Diabetes study.
J Hypertens. 2026 May 15. doi: 10.1097/HJH.0000000000004338.
- ZHOU Y, Chen Y, Chen YL, Chan CM, et al
Exercise-induced changes in blood pressure and pulse rate in relation to cardiac
structure and function assessed by a wearable wrist-type oscillometric blood
pressure monitor.
J Hypertens. 2026;44:1415-1422.
- GUIMARAES-NETO VS, Paiva AMG, Bezerra R, Feitosa ADM, et al
Discrepancies in office blood pressure measurement protocols across international
guidelines: "Houston, we've got a problem.".
J Hypertens. 2026;44:1462-1465.
- LIU W, Liu J, Liu H, Zhang S, et al
The correlation between nursing workload and abnormal 24-h ambulatory blood
pressure profiles in clinical nurses: a cross-sectional study.
J Hypertens. 2026;44:1423-1433.
- ZOCCALI C, Mallamaci F
Hypertension and skeletal fragility: time to add bone to the target-organ list?
J Hypertens. 2026;44:1322-1324.
- BOMFIM GF, Ryan MJ, Bonilha L, McCarthy CG, et al
Hypertension in autoimmune rheumatic diseases: progress made, gaps remain.
J Hypertens. 2026;44:1325-1326.
- CRUICKSHANK JK
Commentary on characterization of participants with a disproportionate degree of
hypertension-mediated organ damage: the Maastricht Study.
J Hypertens. 2026;44:1327-1328.
- ANTAR AS, Sharifi A
Revisiting public understanding of hypertension: methodological considerations
and future directions.
J Hypertens. 2026;44:1466-1467.
- ZENG M, Gnanenthiran SR, Chan DKE, Griffiths R, et al
Reply to comment: Limited public understanding of the risk factors and
complications of hypertension.
J Hypertens. 2026;44:1471-1472.
-
Erratum: Neurofibromatosis 2 alleviates ferroptosis and fibrosis in the aortas of
spontaneously hypertensive rats through the Yes-associated protein pathway.
J Hypertens. 2026;44:1473-1474.
JAMA
- WANG N, Van Der Hoorn S, Pant R, Kumar A, et al
Adverse Effects and Treatment Discontinuation of Blood Pressure-Lowering Drugs
and Combinations: A Network Meta-Analysis.
JAMA. 2026;335:2135-2145.
PLoS One
- PROBANDARI A, Modesty K, Tjung V, Sitepu BE, et al
Potentials, barriers, and strategies for integrating tuberculosis, diabetes
mellitus, and hypertension case management: A scoping review.
PLoS One. 2026;21:e0345708.
- OSEI CSA, Idan JS, Baah-Akyeamfour E, Singh B, et al
Family support mediates the relationship between medication adherence and quality
of life among patients with hypertension in Ghana: A cross-sectional study.
PLoS One. 2026;21:e0351632.
- CHHAM S, Ir P, Olmen JV, Buffel V, et al
Exploring the potential of community health workers in type-2 diabetes and
hypertension management in Cambodia.
PLoS One. 2026;21:e0351958.
- NAKAHARA S, Hirao Y, Fujiuchi B, Matsuda B, et al
Inhaled nitric oxide in fibrotic and advanced interstitial lung disease: A
systematic review and meta-analysis of randomized controlled trials.
PLoS One. 2026;21:e0351862.
Free Medical Abstracts
Privacy Policy
Sponsors
Share
© Amedeo 1997-2016